BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8415309)

  • 21. Thalidomide effective for AIDS-related oral ulcers.
    Thompson C
    Lancet; 1995 Nov; 346(8985):1289. PubMed ID: 7475726
    [No Abstract]   [Full Text] [Related]  

  • 22. Thalidomide and recurrent aphthous stomatitis: a follow-up study.
    Bonnetblanc JM; Royer C; Bedane C
    Dermatology; 1996; 193(4):321-3. PubMed ID: 8993957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thalidomide trial to begin.
    Posit Aware; 1997; 8(2):15. PubMed ID: 11364451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thalidomide for aphthous ulcers in HIV infection.
    Birnkrant D
    N Engl J Med; 1997 Oct; 337(15):1086-7. PubMed ID: 9324641
    [No Abstract]   [Full Text] [Related]  

  • 25. Aphthous stomatitis and its management.
    Santis HR
    Curr Opin Dent; 1991 Dec; 1(6):763-8. PubMed ID: 1807480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aphthous ulcers in HIV-infected patients: treatment with thalidomide.
    Strazzi S; Lebbe C; Geoffray C; Ablon G; Morel P; Verola O; Molina JM
    Genitourin Med; 1992 Dec; 68(6):424-5. PubMed ID: 1487271
    [No Abstract]   [Full Text] [Related]  

  • 27. Thalidomide in the treatment of recurrent necrotic mucocutaneous aphthae.
    Kürkçüoğlu N; Atakan N; Eksioğlu M
    Br J Dermatol; 1985 May; 112(5):632. PubMed ID: 4005164
    [No Abstract]   [Full Text] [Related]  

  • 28. Use of thalidomide in HIV infection.
    Taiwo BO
    AIDS Read; 2001 Oct; 11(10):511-3, 518-9, 523-4. PubMed ID: 11708084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Aphthosis major treated with thalidomide in a patient with AIDS].
    Allegue F; Sarriá Cepeda C; García Rodríguez M
    Enferm Infecc Microbiol Clin; 1991 Feb; 9(2):133-4. PubMed ID: 1854850
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of recurrent aphthae with thalidomide in patients with acquired immunodeficiency syndrome].
    Tercedor J; Ortego N; Ródenas JM; Hernández J
    Med Clin (Barc); 1991 Jun; 97(2):79. PubMed ID: 1895795
    [No Abstract]   [Full Text] [Related]  

  • 31. Refractory aphthous ulceration treated with thalidomide: a report of 10 years' clinical experience.
    Cheng S; Murphy R
    Clin Exp Dermatol; 2012 Mar; 37(2):132-5. PubMed ID: 22007681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical and systemic therapy for recurrent aphthous stomatitis.
    MacPhail L
    Semin Cutan Med Surg; 1997 Dec; 16(4):301-7. PubMed ID: 9421222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Refractory major aphthous stomatitis managed with systemic immunosuppressants: a case report.
    Sarmadi M; Ship JA
    Quintessence Int; 2004 Jan; 35(1):39-48. PubMed ID: 14765640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group.
    Jacobson JM; Greenspan JS; Spritzler J; Ketter N; Fahey JL; Jackson JB; Fox L; Chernoff M; Wu AW; MacPhail LA; Vasquez GJ; Wohl DA
    N Engl J Med; 1997 May; 336(21):1487-93. PubMed ID: 9154767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thalidomide for treatment of oral aphthous ulcers in patients with human immunodeficiency virus: case report and review.
    Ball SC; Sepkowitz KA; Jacobs JL
    Am J Gastroenterol; 1997 Jan; 92(1):169-70. PubMed ID: 8995965
    [No Abstract]   [Full Text] [Related]  

  • 36. Thalidomide for aphthous ulcers in patients infected with the human immunodeficiency virus.
    Weidle PJ
    Am J Health Syst Pharm; 1996 Feb; 53(4):368, 371-2, 378. PubMed ID: 8673657
    [No Abstract]   [Full Text] [Related]  

  • 37. Dynamic salivary cytokine profile of recurrent aphthous stomatitis patients in thalidomide maintenance treatment.
    Wei W; Deng Y; Wang Y; Yao H; Du G; Tang G
    Clin Oral Investig; 2024 Feb; 28(2):140. PubMed ID: 38334890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thalidomide: treatment of choice for aphthous ulcers in patients seropositive for human immunodeficiency virus.
    Ghigliotti G; Repetto T; Farris A; Roy MT; De Marchi R
    J Am Acad Dermatol; 1993 Feb; 28(2 Pt 1):271-2. PubMed ID: 8432932
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of aphthosis with thalidomide and with colchicine].
    Genvo MF; Faure M; Thivolet J
    Dermatologica; 1984; 168(4):182-8. PubMed ID: 6724071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of aphthae with thalidomide.
    Grinspan D; Blanco GF; Agüero S
    J Am Acad Dermatol; 1989 Jun; 20(6):1060-3. PubMed ID: 2754056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.